Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

The risk for COVID-19-related hospitalization was not significantly different between vaccinated older adults with vs without age-restrictive access to nirmatrelvir-ritonavir.

Michael Rogers, associate commissioner for inspections and investigations at the US FDA, announced his decision to retire.

Metformin use in patients with HIV and type 2 diabetes who had at least 2 years of exposure to effective ART showed no significant effect on immune reconstitution.

From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge.

A quality improvement program can improve recommended antibiotic duration in children for acute otitis media and community-acquired pneumonia.

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

The head of the US FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies.

According to the US CDC, a salmonella outbreak tied to backyard poultry has made at least 7 people sick across 6 states.

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.